Cargando…
Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer
Patients with gastric cancer typically face gastrectomies even when few or no nodal metastases are reported. Current procedures poorly predict lymphatic metastases; thus, evaluation of target molecules expressed on cancer cell membranes is necessary for in vivo detection. However, marker development...
Autores principales: | Matsusaka, Keisuke, Ushiku, Tetsuo, Urabe, Masayuki, Fukuyo, Masaki, Abe, Hiroyuki, Ishikawa, Shumpei, Seto, Yasuyuki, Aburatani, Hiroyuki, Hamakubo, Takao, Kaneda, Atsushi, Fukayama, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325433/ https://www.ncbi.nlm.nih.gov/pubmed/27580354 http://dx.doi.org/10.18632/oncotarget.11638 |
Ejemplares similares
-
Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens
por: Matsusaka, Keisuke, et al.
Publicado: (2016) -
TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection
por: Namba-Fukuyo, Hiroe, et al.
Publicado: (2016) -
Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection
por: Funata, Sayaka, et al.
Publicado: (2017) -
Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset
por: Tanaka, Atsushi, et al.
Publicado: (2018) -
RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases
por: Ushiku, Tetsuo, et al.
Publicado: (2015)